IL13 and COVID-19: Within this set, there are several immune-related processes known to be implicated in COVID-19 severity such as ‘Interleukin-5 and interleukin-13 signalling’ [57,58] and ‘Caspase activation via death receptors in the presence of ligand’ [58].